Literature DB >> 2029205

Characterisation of the size and composition of circulating immune complexes in patients with rheumatoid arthritis.

R A Mageed1, J R Kirwan, P W Thompson, D A McCarthy, E J Holborow.   

Abstract

The size and composition of circulating immune complexes in the sera of patients with rheumatoid arthritis (RA) were studied in relation to different manifestations of the disease. Circulating immune complexes from the sera of 94 patients (50 with extra-articular disease) and 10 matched controls were fractionated by sucrose density gradient ultracentrifugation. The composition, immunoglobulin and rheumatoid factor (RF) concentrations within each of the fractions were determined by a sensitive enzyme linked immunosorbent assay (ELISA). Intermediate size (14S-21S) IgG complexes containing RF activity and 22S IgG-IgM RF complexes were found in the sera of 40 patients with RA, while intermediate size complexes of self associated IgG RF and larger size complexes (greater than 22S) of IgG RF and IgM RF were associated with extra-articular features of RA (50% of extra-articular disease). Complexes containing IgA were found in the sera of many patients with RA, and dimeric IgA RF mainly in patients with extra-articular disease. These results support the view that whereas small size circulating immune complexes are of no primary pathogenic importance in synovitis, large size (greater than 22S) circulating immune complexes may play a role in extra-articular disease in RA. Current understanding of the formation of large complexes provides a biological explanation for their occurrence and effects.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2029205      PMCID: PMC1004392          DOI: 10.1136/ard.50.4.231

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  30 in total

1.  Characterization of IgG complexes in eluates from rheumatoid tissue.

Authors:  E Munthe; J B Natvig
Journal:  Clin Exp Immunol       Date:  1971-02       Impact factor: 4.330

2.  Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis. Partial characterization and relationship to lowered complement levels.

Authors:  R J Winchester; V Agnello; H G Kunkel
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

3.  Immune complex deposition and coronary vasculitis in systemic lupus erythematosus. Report of two cases.

Authors:  S M Korbet; M M Schwartz; E J Lewis
Journal:  Am J Med       Date:  1984-07       Impact factor: 4.965

4.  Capacity to solubilize immune complexes in sera and synovial fluids from patients with rheumatoid arthritis.

Authors:  E Dayer; J C Gerster; M T Aguado; P H Lambert
Journal:  Arthritis Rheum       Date:  1983-02

5.  The complement fixing properties and class distribution of rheumatoid factors (antiglobulins) in rheumatoid arthritis and other diseases.

Authors:  R E March; J S Reeback; E J Holborow; V E Jones; R K Jacoby
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

6.  The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.

Authors:  B E Bourke; I K Moss; P Mumford; A Horsfall; R N Maini
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

7.  Evaluation of six tests for circulating IgG complexes with special reference to IgM rheumatoid factors: analysis of systemic lupus erythematosus and rheumatoid arthritis series.

Authors:  O Wager; P Lindström; J A Räsänen; R Kekomäki; B Ziola; A Salmi; H Isomäki; B Skrifvars; K Penttinen
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

8.  Studies into the occurrence of soluble antigen-antibody complexes in disease. V. Second assessment of correlation between the rheumatoid biologically active factor (RBAF) and the clinical features of rheumatoid arthritis.

Authors:  M B Urowitz; D A Gordon; I Broder
Journal:  Arthritis Rheum       Date:  1973 Mar-Apr

9.  Prospective study of early rheumatoid arthritis. II. Association of rheumatoid factor isotypes with fluctuations in disease activity.

Authors:  R H Withrington; I Teitsson; H Valdimarsson; M H Seifert
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

10.  Prospective study of early rheumatoid arthritis. I. Prognostic value of IgA rheumatoid factor.

Authors:  I Teitsson; R H Withrington; M H Seifert; H Valdimarsson
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

View more
  7 in total

1.  Effect of complement on sizes of model immune complexes.

Authors:  L B Korolevskaya; K V Shmagel
Journal:  Dokl Biochem Biophys       Date:  2014-11-04       Impact factor: 0.788

2.  Dominant suppression of inflammation by glycan-hydrolyzed IgG.

Authors:  Kutty Selva Nandakumar; Mattias Collin; Kaisa E Happonen; Allyson M Croxford; Susanna L Lundström; Roman A Zubarev; Merrill J Rowley; Anna M Blom; Rikard Holmdahl
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-13       Impact factor: 11.205

3.  Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis.

Authors:  L Vasiliauskiene; A Wiik; M Høier-Madsen
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

Review 4.  FcgammaRII and multi-system autoimmune disease.

Authors:  Nicholas C van de Velde; Patricia L Mottram; P Mark Hogarth
Journal:  Springer Semin Immunopathol       Date:  2006-11-08

5.  Variation in the serum IgA concentration and the production of IgA in vitro in rheumatoid arthritis treated by sulfasalazine.

Authors:  C Jorgensen; C Bologna; J M Anaya; T Reme; J Sany
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

6.  Streptococcal Endo-β-N-Acetylglucosaminidase Suppresses Antibody-Mediated Inflammation In Vivo.

Authors:  Kutty Selva Nandakumar; Mattias Collin; Kaisa E Happonen; Susanna L Lundström; Allyson M Croxford; Bingze Xu; Roman A Zubarev; Merrill J Rowley; Anna M Blom; Christian Kjellman; Rikard Holmdahl
Journal:  Front Immunol       Date:  2018-07-16       Impact factor: 7.561

Review 7.  Circadian Clock and Complement Immune System-Complementary Control of Physiology and Pathology?

Authors:  Pooja Shivshankar; Baharan Fekry; Kristin Eckel-Mahan; Rick A Wetsel
Journal:  Front Cell Infect Microbiol       Date:  2020-08-14       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.